Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals for the manufacturing of a generic product for filing in Japan. ...
read more
Wednesday, August 04, 2021
PHASTAR, a specialist biometrics contract research organization offering industry-leading data management, data science, statistical consulting and clinical trial reporting services, announced the appointment of Chuck Gelb as Chief Commercial Officer...
read more
Wednesday, August 04, 2021
WuXi STA announced that it has completed the acquisition of a drug product manufacturing facility in Couvet, Switzerland from Bristol Myers Squibb. WuXi STA first announced its plans to purchase the facility earlier this year. The acquisition will ...
read more
Wednesday, August 04, 2021
SPI Pharma, a leading supplier of solutions to pharmaceutical formulation marketers is pleased to announce a new, exclusive agreement with Azelis Americas, a leading innovation service provider in the specialty chemicals and food ingredients industry...
read more
Wednesday, August 04, 2021
Veranex announced the acquisition of Experien Group, a provider of regulatory, quality and clinical consulting services to medtech companies. Veranex provides the medtech industry with integrated product development strategies and services across the...
read more
Wednesday, August 04, 2021
DisperSol Technologies, a clinical-stage pharmaceutical company developing new treatments for oncology and rare diseases, and Catalent, a global provider of advanced delivery technologies...
read more
Wednesday, August 04, 2021
Evonik has acquired German biotech company JeNaCell. The acquisition expands Evonik’s biomaterials portfolio to provide biotechnologically derived cellulose. The nature-identical material developed by JeNaCell is used in medical technology and ...
read more
Wednesday, August 04, 2021
Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) will include Daikyo Crystal Zenith® (CZ) container-closure components, offered by West Pharmaceutical Services, Inc. (West), as part of its aseptic ...
read more
Wednesday, August 04, 2021
Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies may now be performed for Boehringer Ingelheim to assess the added value Nanoform’s award-winning CESS® technology can deliver to its drug ...
read more
Omnicell, Inc., a leading provider of medication management solutions and adherence tools for health systems and pharmacies, announced a definitive agreement with pharmacy software solutions provider FDS Amplicare to acquire its business for total ...
read more
Centogene N.V., a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced the appointment of Dr. Patrice P. Denèfle as Chief Scientific Officer (CSO). Dr. Denèfle will join ...
read more
Catalent’s OptiDose Design Solution, led by Catalent’s scientific advisors, uses a design approach that combines data-driven scientific tools with Catalent’s extensive development expertise. Integrating pharmaceutics, and dose form design target ...
read more
Genezen Laboratories Inc. a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has further strengthened its senior leadership team with the appointment of Brok Weichbrodt as Vice President of Operations.
read more
Rho, a full-service contract research organization (CRO), announced its Human Epidemiology and Response to SARS-CoV-2 (HEROS) study, to help determine the rate of the new coronavirus infection in children and their families in the U.S. has been ...
read more
BioStem Technologies Inc., a pre-clinical-stage biotechnology company focused on elements of perinatal tissue for use in regenerative therapies; announced that it has engaged Biologics Consulting, a full-service regulatory and product development ...
read more